Korean Market
OWNR
Samsung Biologics
★
Samsung Biologics Exec Jo Seong-hwan Withdraws 50 Shares from ESOP
 05/20/2026, 05:05 PM
PERI
Samsung Biologics
★★★
Samsung Biologics: Strong Q1 2026 Results and US Production Base Acquisition
 05/15/2026, 04:12 PM
PERI
Samsung Biologics
★★
Samsung Biologics: 2025 Consolidated Revenue +30%, Operating Profit +57%... Spin-off Focuses on CDMO
 05/15/2026, 03:50 PM
EXCH
Samsung Biologics
★
Samsung Life Insurance Special Account Slightly Sells Samsung Biologics Shares; No Change in Major Shareholder Stake
 05/04/2026, 04:49 PM